Effectiveness of an Intelligent Voice Outbound Call System as an Adjunct to Usual Care for Health Management in Older Community-dwelling Patients with "Three Highs" Multimorbidity: a Randomized Controlled Trial
1. Fangzhuang Community Health Service Center of Fengtai District, Beijing 100071, China 2. National Health Commission Capacity Building and Continuing Education Center (National Health Commission Party School), Beijing 100083, China 3. Xiluoyuan Community Health Service Center of Fengtai District, Beijing 100077, China
WEI Xuejuan,WANG Lihua,WANG Li, et al. Effectiveness of an Intelligent Voice Outbound Call System as an Adjunct to Usual Care for Health Management in Older Community-dwelling Patients with "Three Highs" Multimorbidity: a Randomized Controlled Trial[J]. Chinese General Practice, 2026, 29(31): 4635-4640. DOI: 10.12114/j.issn.1007-9572.2026.0123.
魏学娟,王利华,王丽等. 智能语音外呼辅助传统干预对社区老年"三高"共病患者健康管理的效果研究:一项随机对照试验[J]. 中国全科医学, 2026, 29(31): 4635-4640. DOI: 10.12114/j.issn.1007-9572.2026.0123.
Table 1 Comparison of key design features between integrated AI outbound call systems for "three-highs" management and single-disease AI outbound call systems
Table 1 Comparison of key design features between integrated AI outbound call systems for "three-highs" management and single-disease AI outbound call systems
干预环节
单病种AI外呼
"三高"整合型AI外呼
设计差异的目的
随访内容
询问单项指标(如仅血压值)
同一通话中顺序询问血压、血糖、血脂指标
提高综合认知,避免重复呼叫
饮食/运动建议
单项建议(如低盐)
整合建议(低盐+低糖+低饱和脂肪)
简化患者认知决策,避免多重标准带来的执行困难
用药提醒
针对单病种用药
基于"三高"常用药物组合进行互动确认
降低多重用药的漏服、重复用药风险
风险评估
依据单一指标
综合三项指标提示ASCVD总体风险等级
使患者更直观理解"三高"共病的协同风险,提升干预动机
Table 2 Comparison of baseline characteristics between the two groups of "three highs" patients with hypertension, hyperglycemia, and hyperlipidemia
KesD, AslanG K, et al. The effect of nurse-led telephone support on adherence to blood pressure control and drug treatment in individuals with primary hypertension: a randomized controlled study[J]. Int J Nurs Pract, 2022, 28(3): e12995. DOI: 10.1111/ijn.12995.
[12]
StrattonI M, AdlerA I, NeilH A, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study[J]. BMJ, 2000, 321(7258): 405-412. DOI: 10.1136/bmj.321.7258.405.
[13]
BretschneiderM P, KolasiniskaA B, SomvarskaL, et al. Evaluation of the impact of mobile health appvitadio in patients with type 2 diabetes: randomized controlled trial[J]. J Med Internet Res, 2025, 27: e68648. DOI: 10.2196/68648.
[14]
MarxN, FedericiM, SchuttK, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes[J]. Eur Heart J, 2023, 44(39): 4043-4140. DOI: 10.1093/eurheartj/ehad192.